|Day Low/High||33.97 / 34.26|
|52 Wk Low/High||29.41 / 37.39|
The most recent short interest data has been released for the 03/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Pfizer Inc. (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ ® (tofacitinib citrate) 5 mg twice daily (BID) oral tablets in combination with methotrexate (MTX) for the treatment of...
Wall Street could be in for a rocky week in the wake of the Republicans' failure to repeal and replace Obamacare as promised.
The vote on repealing and replacing Obamacare has been pulled from the House floor.
Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that TRUMENBA ® (Meningococcal Group B...
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.
Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.
Obamacare? Trumpcare? These stocks don't care.
Here's a rundown of four technical setups that are showing solid trading potential.
Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.
Fired former U.S. Attorney Preet Bharara was investigating stock trades made by Health and Human Services Secretary Tom Price, according to one report.
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc.
Investor sentiment soured on Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.
Stocks are slightly lower by early afternoon Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.
Early morning gains quickly evaporate on Thursday as a selloff in health care overshadows the Federal Reserve's decision a day earlier to raise interest rates.
Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its oral Janus kinase (JAK) inhibitor, XELJANZ ® (tofacitinib citrate), in China for the...
AstraZeneca's PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo.
Pfizer Inc. today announced that Zavicefta , a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gram-negative bacterial infections requiring hospitalization, is now available...
Where should you put your money in March? TheStreet has the strategies and analysis to help guide your investment moves for the month.
Why the name is sagging, and what it will take to spur the sector higher.
While it's not a surprise that Global Blood is a takeout target, the timing of Novo Nordisk's interest in the company comes as a surprise, according to a stock analyst.
The Democrats aim to generate public opposition to repeal by offering amendments that highlight fears the GOP plan will result in more expensive insurance and fewer people with coverage.
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D'Amelio, Executive Vice President, Business Operations and Chief Financial Officer, at the Barclays Global Healthcare...
In light of International Women's Day, State Street Global Advisors is pushing companies to put more women on boards, and preparing for proxy battles for companies that don't.
Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.